Diamyd Medical has reached alignment with the U.S. Food and Drug Administration (FDA) to accelerate the primary efficacy readout in its ongoing pivotal, registrational Phase 3 DIAGNODE-3 trial in type ...
During week 52, 22-26 December 2025, Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 240,000 own B shares (ISIN: SE0016787071), corresponding to 0.07% of outstanding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback